[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Johnsonnowhn Johnson TerrellJohnson Terrell posts on X about target, products, $qdel, $note the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence cryptocurrencies XXXX% stocks XXXX%
Social topic influence target 50%, products 12.5%, $qdel #1, $note 4.17%, level 4.17%, $tara 4.17%, $abeo 4.17%, the first 4.17%, sealed air corp 4.17%, $see XXXX%
Top accounts mentioned or mentioned by @maximizebelief2
Top assets mentioned QuidelOrtho Corporation Common Stock (QDEL) Taraxa (TARA) Sealed Air Corp (SEE) Upexi Inc. (UPXI) Atkore Inc. (ATKR)
Top posts by engagements in the last XX hours
"$NOTE Target Price: $XXXX If the price holds above the $XXXX support level a rebound is possible. Resistance is at $5.20"
X Link 2025-10-21T12:38Z 3513 followers, XXX engagements
"$TARA Target Price: $XXXX New data from the Phase X ADVANCED-2 trial in patients with non-muscle-invasive bladder cancer (NMIBC) who have not received BCG treatment could trigger a short-term stock price rebound"
X Link 2025-12-03T13:42Z 3514 followers, 1463 engagements
"$ABEO Target Price: $XXXX. The first commercial patient received treatment at Stanford Children's Hospital marking a milestone for RDEB gene therapy. The company plans to treat more patients by early 2026 which could drive the stock price up in the short term"
X Link 2025-12-08T13:15Z 3515 followers, XXX engagements
"Sealed Air Corporation ( $SEE) will be acquired by CD&R for $XXXX billion"
X Link 2025-11-17T13:05Z 3514 followers, XXX engagements
"$UPXI Target Price: $XXXX Upexi Inc. is a company that develops manufactures and distributes consumer products primarily through a direct-to-consumer model"
X Link 2025-11-19T14:24Z 3512 followers, XXX engagements
"Electrical component manufacturer $ATKR said Thursday that its board of directors and management team are considering various options including the possibility of selling or merging the company"
X Link 2025-11-20T13:14Z 3516 followers, XXX engagements
"$QDEL Target Price: $XXXXX QuidelOrtho Corp. is an in vitro diagnostics company focused on the research and development and production of diagnostic products"
X Link 2025-11-21T13:58Z 3514 followers, XXX engagements
"The stock $QDEL recommended last week has reached or even exceeded the target price"
X Link 2025-11-25T13:03Z 3513 followers, XXX engagements
"$PDSB Target price: $XXXX PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers including head and neck cancer prostate cancer breast cancer cervical cancer anal cancer and other cancers"
X Link 2025-12-02T14:00Z 3512 followers, XXX engagements
"$MDCX Target price: $XXXX The basal cell carcinoma (BCC) market is huge (more than X million cases per year) and the non-surgical advantages of SKNJCT-003 have the potential to revolutionize traditional treatment methods"
X Link 2025-12-05T13:47Z 3514 followers, XXX engagements
"$PRME Target price: $XXXX PRME targets the gene editing market with its highly precise Prime Editing technology. NEJM-published human data shows strong safety/efficacy in CGD; ASH 2025 feedback expected to accelerate FDA approval"
X Link 2025-12-08T13:36Z 3512 followers, XXX engagements
"$IINN Target Price: $XXXX A dual-lumen device covering the INSPIRA ART system was granted a Japanese patent today (valid until 2041) and this positive feedback may drive a short-term rebound"
X Link 2025-12-09T13:45Z 3512 followers, XXX engagements
"$RZLV Target Price: $XXXX Rezolve AI Plc is a mobile commerce company whose cutting-edge interactive platform is powered by artificial intelligence and machine learning"
X Link 2025-11-20T14:14Z 3511 followers, 2209 engagements
"$CRBP Target price: $XXXXX The Phase 1a results showed good safety and preliminary weight loss. The Phase 1b study (CANYON-1) is now underway with completion expected in summer 2026 offering a potential catalyst amid high GLP-1 demand"
X Link 2025-12-11T13:40Z 3511 followers, XXX engagements